Auto saved by Logseq

2 months ago · ed87ed3370
parent 61f78f0a22
commit ed87ed3370
1 changed files with 1 additions and 1 deletions
--- a/2025___Application.md
+++ b/2025___Application.md
@ -1,6 +1,6 @@
 # [[2024/10/30]]
 	- **Título**: Fixed dose albenzadole/ivermectin coformulation, an innovative tool to help countries achieve their NTD control goals in a post-donation era
 	- **Description**: The fixed-dose coformulation of albendazole and ivermectin is the result of 10+ years of innovations carried out by African and European organizations working through public-private partnerships. 
-	  This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a pivotal trial and is currently being evaluated by the European Medicines Agency under the EU-M4All procedure
+	  This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a 2022/2023 phase II/III pivotal trial and is currently being evaluated by the European Medicines Agency (EMA) under the EU-M4All procedure and Ghana's FDA.
 	  The fixed-dose combination of albendazole and ivermectin provides a novel approach to mass drug administration campaigns that simplifies logistics while providing better efficacy against more species of helminths.
 -